|
|
||||||||
Vol. 51, Issue 4, 629-650, December 1999
Rappaport Family Institute for Research in the Medical Sciences,
Haifa, Israel (M.G.); Department of Pharmacology (M.G., I.B., R.S.,
L.V.) and Laboratory for Research in Anesthesia, Pain and Neuroscience
(Y.K.), The Bruce Rappaport Faculty of Medicine, Technion-Israel
Institute of Technology, Haifa, Israel; Department of Anesthesiology,
Ha'Emek Medical Center, Afula, Israel (Y.K.); Endocrinology Institute,
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel (G.W.); Geha Mental
Health Center, Felsenstein Medical Research Center, Rabin Medical
Center, Beilinson Campus, Petah Tiqva, Israel (A.W.); and Sackler
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (A.W.)
I. Introduction
II. The Peripheral Benzodiazepine Receptor: Molecular Identity
III. Endogenous Ligands for Peripheral Benzodiazepine Receptors
IV. Role of Peripheral Benzodiazepine Receptors in Cellular
Respiration
V. Peripheral Benzodiazepine Receptors in Endocrine System and
Steroid Regulation
A. Regulation of Steroidogenesis by Peripheral Benzodiazepine
Receptors
B. Peripheral Benzodiazepine Receptors in Female Genital Tract
1. Ovary.
2. Uterus and Oviduct.
3. Adrenal.
4. Mammary Gland.
C. Peripheral Benzodiazepine Receptors in Male Genital Tract
VI. Peripheral Benzodiazepine Receptors under Pathological
Conditions
A. Stress Response
1. Relevance of Peripheral Benzodiazepine Receptors to
Stress.
2. Peripheral Benzodiazepine Receptor Ligands and
Behavior.
3. Involvement of Peripheral Benzodiazepine Receptors in Acute
Stress.
4. Involvement of Peripheral Benzodiazepine Receptors in Chronic
Stress.
5. Putative Mechanisms Involved in Peripheral Benzodiazepine
Receptor Response to Stress.
B. Anxiety Disorders
1. Generalized Anxiety Disorder.
2. Panic Disorder.
3. Generalized Social Phobia.
4. Post-Traumatic Stress Disorder (PTSD).
5. Obsessive-Compulsive Disorder (OCD).
C. Mood Disorders
D. Neurodegenerative Disorders
1. Parkinson's Disease.
2. Alzheimer's Disease.
E. Peripheral Benzodiazepine Receptors and Brain Damage
1. Peripheral Benzodiazepine Receptors and Neurotoxic Brain
Damage.
2. Peripheral Benzodiazepine Receptors and Traumatic-Ischemic Brain
Damage.
VII. Peripheral Benzodiazepine Receptors in Cancer and in Immune
Function
VIII. Summary and Future Prospects
Acknowledgments
References
This article has been cited by other articles:
![]() |
M. L. James, R. R. Fulton, J. Vercoullie, D. J. Henderson, L. Garreau, S. Chalon, F. Dolle, S. Selleri, D. Guilloteau, and M. Kassiou DPA-714, a New Translocator Protein-Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization J. Nucl. Med., May 1, 2008; 49(5): 814 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Brown, M. Fujita, Y. Fujimura, J.-S. Liow, M. Stabin, Y. H. Ryu, M. Imaizumi, J. Hong, V. W. Pike, and R. B. Innis Radiation Dosimetry and Biodistribution in Monkey and Man of 11C-PBR28: A PET Radioligand to Image Inflammation J. Nucl. Med., December 1, 2007; 48(12): 2072 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Zhang, K. Kumata, J. Maeda, K. Yanamoto, A. Hatori, M. Okada, M. Higuchi, S. Obayashi, T. Suhara, and K. Suzuki 11C-AC-5216: A Novel PET Ligand for Peripheral Benzodiazepine Receptors in the Primate Brain J. Nucl. Med., November 1, 2007; 48(11): 1853 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import Mol. Endocrinol., March 1, 2007; 21(3): 589 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Turkheimer, P. Edison, N. Pavese, F. Roncaroli, A. N. Anderson, A. Hammers, A. Gerhard, R. Hinz, Y. F. Tai, and D. J. Brooks Reference and Target Region Modeling of [11C]-(R)-PK11195 Brain Studies J. Nucl. Med., January 1, 2007; 48(1): 158 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Chen and T. R. Guilarte Imaging the Peripheral Benzodiazepine Receptor Response in Central Nervous System Demyelination and Remyelination Toxicol. Sci., June 1, 2006; 91(2): 532 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Cagnin, S D Taylor-Robinson, D M Forton, and R B Banati In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy Gut, April 1, 2006; 55(4): 547 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Costa, A. Salvetti, L. Rossi, F. Spinetti, A. Lena, B. Chelli, M. Rechichi, E. Da Pozzo, V. Gremigni, and C. Martini Peripheral Benzodiazepine Receptor: Characterization in Human T-Lymphoma Jurkat Cells Mol. Pharmacol., January 1, 2006; 69(1): 37 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jamin, J.-M. Neumann, M. A. Ostuni, T. K. N. Vu, Z.-X. Yao, S. Murail, J.-C. Robert, C. Giatzakis, V. Papadopoulos, and J.-J. Lacapere Characterization of the Cholesterol Recognition Amino Acid Consensus Sequence of the Peripheral-Type Benzodiazepine Receptor Mol. Endocrinol., March 1, 2005; 19(3): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hauet, Z.-X. Yao, H. S. Bose, C. T. Wall, Z. Han, W. Li, D. B. Hales, W. L. Miller, M. Culty, and V. Papadopoulos Peripheral-Type Benzodiazepine Receptor-Mediated Action of Steroidogenic Acute Regulatory Protein on Cholesterol Entry into Leydig Cell Mitochondria Mol. Endocrinol., February 1, 2005; 19(2): 540 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sanna, G. Talani, F. Busonero, M. G. Pisu, R. H. Purdy, M. Serra, and G. Biggio Brain Steroidogenesis Mediates Ethanol Modulation of GABAA Receptor Activity in Rat Hippocampus J. Neurosci., July 21, 2004; 24(29): 6521 - 6530. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Giatzakis and V. Papadopoulos Differential Utilization of the Promoter of Peripheral-Type Benzodiazepine Receptor by Steroidogenic Versus Nonsteroidogenic Cell Lines and the Role of Sp1 and Sp3 in the Regulation of Basal Activity Endocrinology, March 1, 2004; 145(3): 1113 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boitano, J. A. Ellman, G. D. Glick, and A. W. Opipari Jr. The Proapoptotic Benzodiazepine Bz-423 Affects the Growth and Survival of Malignant B Cells Cancer Res., October 15, 2003; 63(20): 6870 - 6876. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B Banati Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain Br. Med. Bull., March 1, 2003; 65(1): 121 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Everett, M. Barry, X. Sun, S. F. Lee, C. Frantz, L. G. Berthiaume, G. McFadden, and R. C. Bleackley The Myxoma Poxvirus Protein, M11L, Prevents Apoptosis by Direct Interaction with the Mitochondrial Permeability Transition Pore J. Exp. Med., November 4, 2002; 196(9): 1127 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gazouli, Z. Han, and V. Papadopoulos Identification of a Peptide Antagonist to the Peripheral-Type Benzodiazepine Receptor That Inhibits Hormone-Stimulated Leydig Cell Steroid Formation J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 627 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maaser, P. Grabowski, A. P. Sutter, M. Hopfner, H.-D. Foss, H. Stein, G. Berger, M. Gavish, M. Zeitz, and H. Scherubl Overexpression of the Peripheral Benzodiazepine Receptor Is a Relevant Prognostic Factor in Stage III Colorectal Cancer Clin. Cancer Res., October 1, 2002; 8(10): 3205 - 3209. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Klonowski-Stumpe, R. Fischer, R. Reinehr, R. Luthen, and D. Haussinger Apoptosis in activated rat pancreatic stellate cells Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G819 - G826. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukuda, T. Shoda, H. Mima, and H. Uga Midazolam Induces Expression of c-Fos and EGR-1 by a Non-GABAergic Mechanism Anesth. Analg., August 1, 2002; 95(2): 373 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Szewczyk and L. Wojtczak Mitochondria as a Pharmacological Target Pharmacol. Rev., March 1, 2002; 54(1): 101 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazzone, C. Cusa, I. Mazzucchelli, M. Vezzoli, E. Ottini, R. Pacifici, P. Zuccaro, and C. Falcone Increased production of inflammatory cytokines in patients with silent myocardial ischemia J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1895 - 1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Rady and J. M. Fujimoto Confluence of Antianalgesic Action of Diverse Agents through Brain Interleukin1beta in Mice J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 659 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Johnston, W. Jiang, T. Chu, and B. Levine Identification of Genes Involved in the Host Response to Neurovirulent Alphavirus Infection J. Virol., November 1, 2001; 75(21): 10431 - 10445. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cagnin, R. Myers, R. N. Gunn, A. D. Lawrence, T. Stevens, G. W. Kreutzberg, T. Jones, and R. B. Banati In vivo visualization of activated glia by[11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion Brain, October 1, 2001; 124(10): 2014 - 2027. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |